{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-066078","form_type":"8-K","ticker":"BNBX","cik":"0000744452","company_name":"BNB PLUS CORP.","filed_at":"2025-07-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.271912+00:00","generated_at":"2026-05-18T09:23:18.359746+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Applied DNA regains Nasdaq minimum bid price compliance; hearing cancelled","bullets":["On July 2, 2025, Nasdaq notified Applied DNA it regained compliance with $1.00 minimum bid price rule (Rule 5550(a)(2)).","The July 15, 2025 hearing before the Nasdaq Hearings Panel has been cancelled.","Applied DNA's common stock will continue to be listed and traded on Nasdaq."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-066078","json":"https://secwatch.observer/filing/0001104659-25-066078.json","markdown":"https://secwatch.observer/filing/0001104659-25-066078.md","text":"https://secwatch.observer/filing/0001104659-25-066078.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/744452/000110465925066078/0001104659-25-066078-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/744452/000110465925066078/tm2519995d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T09:23:18.359746+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}